FDA approves first generic of Novo Nordisk’s Victoza

by
Contributor since / Followers
2 days ago
Liraglutide

Hailshadow/iStock via Getty Images

  • The U.S. FDA has approved the first generic version of Novo Nordisk’s (NVO) GLP-1 for type 2 diabetes, Victoza (liraglutide).
  • The approval was granted to Hikma Pharmaceuticals USA.
  • The agency noted that brand-named Victoza is currently in shortage.
  • An authorized
Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *